Performance characteristics for a diagnostic molecular test for EGFR gene mutations, KRAS mutations, and EGFR amplification in lung adenocarcinomas

被引：0
|
作者：
Caglar, D [1 ]
Dacic, S [1 ]
Mantha, GS [1 ]
Hunt, JL [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1415
引用
收藏
页码：304A / 304A
页数：1
相关论文
共 50 条
  • [21] Concurrent EGFR and ALK Mutations in KRAS-Mutant Lung Adenocarcinomas and Their Clinical Behavior
    Wood, Kevin C.
    Hensing, Thomas
    Won, Brian
    Vokes, Everett
    Salgia, Ravi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S453 - S454
  • [22] EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
    Sahnane, Nora
    Frattini, Milo
    Bernasconi, Barbara
    Zappa, Francesco
    Schiavone, Giovanna
    Wannesson, Luciano
    Antonelli, Paola
    Balzarini, Piera
    Sessa, Fausto
    Mazzucchelli, Luca
    Tibiletti, Maria Grazia
    Martin, Vittoria
    CLINICAL LUNG CANCER, 2016, 17 (01) : 56 - 61
  • [23] Somatic mutations of EGFR and KRAS in pure bronchioloalveolar carcinomas and adenocarcinomas of the lung with bronchioloalveolar features
    Dahabreh, I. J.
    Murray, S.
    Spiliadi, H. T.
    Karagiani, E. A.
    Stamatelopoulos, A.
    Vassilikos, K.
    Zanos, G.
    Janinis, J.
    Dahabreh, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] ALK rearrangement, EGFR, KRAS mutations and MET amplification are not exclusive in bronchial-pulmonary adenocarcinomas
    Carvalho, L.
    Silva, M.
    Alarcao, A.
    Ferreira, T.
    d'Aguiar, M. J.
    Ladeirinha, A. F.
    Sousa, V.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 134 - 134
  • [25] EGFR and KRAS mutations in lung adenocarcinomas: two contrasting and mutually exclusive mechanisms for pathogenesis
    Mitsudomi, Tetsuya
    Gazdar, Adi F.
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S119 - S121
  • [26] Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma
    Janjigian, Yelena Y.
    Kris, Mark G.
    Pao, William
    Marks, Jenifer L.
    Zheng, Junting
    Shen, Ronglai
    Dycoco, Joseph P.
    Park, Bernard J.
    Riely, Grey J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S333 - S333
  • [27] EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Marks, Jenifer L.
    Broderick, Stephen
    Seshan, Venkatraman E.
    Zakowski, Maureen F.
    Li, Allan
    Wilson, Richard
    Kris, Mark G.
    Ladanyi, Mark
    Rusch, Valerie W.
    Pao, William
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S481
  • [28] KIF5B-RET fusion gene and oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas.
    Kang, Jin Hyoung
    Kim, Jeong-Oh
    Lee, Jieun
    Shin, Jung-Young
    Oh, Ji-Eun
    Jung, Chan-Kwon
    Park, Jae Gil
    Sung, Sook-Whan
    Bae, Sang-Ju
    Min, Hyun-Jung
    Kim, Dowon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
    Arcila, Maria E.
    Nafa, Khedoudja
    Chaft, Jamie E.
    Rekhtman, Natasha
    Lau, Christopher
    Reva, Boris A.
    Zakowski, Maureen F.
    Kris, Mark G.
    Ladanyi, Marc
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (02) : 220 - 229
  • [30] The Molecular Landscape of Lung Adenocarcinomas with Activating EGFR Gene Mutations Determined by Targeted-Sequencing
    Nicos, M.
    Wojas-Krawczyk, K.
    Krawczyk, P.
    Calka, P.
    Ciesielka, M.
    Reszka, K.
    Milanowski, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S587 - S587
12345